These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

510 related articles for article (PubMed ID: 23419425)

  • 1. Determinants of plasma concentrations of perfluoroalkyl substances in pregnant Norwegian women.
    Brantsæter AL; Whitworth KW; Ydersbond TA; Haug LS; Haugen M; Knutsen HK; Thomsen C; Meltzer HM; Becher G; Sabaredzovic A; Hoppin JA; Eggesbø M; Longnecker MP
    Environ Int; 2013 Apr; 54():74-84. PubMed ID: 23419425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Menstrual cycle characteristics as determinants of plasma concentrations of perfluoroalkyl substances (PFASs) in the Norwegian Mother and Child Cohort (MoBa study).
    Singer AB; Whitworth KW; Haug LS; Sabaredzovic A; Impinen A; Papadopoulou E; Longnecker MP
    Environ Res; 2018 Oct; 166():78-85. PubMed ID: 29879567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perfluoroalkyl substances and lipid concentrations in plasma during pregnancy among women in the Norwegian Mother and Child Cohort Study.
    Starling AP; Engel SM; Whitworth KW; Richardson DB; Stuebe AM; Daniels JL; Haug LS; Eggesbø M; Becher G; Sabaredzovic A; Thomsen C; Wilson RE; Travlos GS; Hoppin JA; Baird DD; Longnecker MP
    Environ Int; 2014 Jan; 62():104-12. PubMed ID: 24189199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reliability of perfluoroalkyl substances in plasma of 100 women in two consecutive pregnancies.
    Papadopoulou E; Haug LS; Sabaredzovic A; Eggesbø M; Longnecker MP
    Environ Res; 2015 Jul; 140():421-9. PubMed ID: 25957838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of diet with per- and polyfluoroalkyl substances in plasma and human milk in the New Hampshire Birth Cohort Study.
    Wang Y; Gui J; Howe CG; Emond JA; Criswell RL; Gallagher LG; Huset CA; Peterson LA; Botelho JC; Calafat AM; Christensen B; Karagas MR; Romano ME
    Sci Total Environ; 2024 Jul; 933():173157. PubMed ID: 38740209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of plasma concentrations of perfluoroalkyl and polyfluoroalkyl substances in pregnant women from a birth cohort in Shanghai, China.
    Tian Y; Zhou Y; Miao M; Wang Z; Yuan W; Liu X; Wang X; Wang Z; Wen S; Liang H
    Environ Int; 2018 Oct; 119():165-173. PubMed ID: 29958117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variability of perfluoroalkyl substance concentrations in pregnant women by socio-demographic and dietary factors in a Spanish birth cohort.
    Manzano-Salgado CB; Casas M; Lopez-Espinosa MJ; Ballester F; Martinez D; Ibarluzea J; Santa-Marina L; Schettgen T; Vioque J; Sunyer J; Vrijheid M
    Environ Int; 2016; 92-93():357-65. PubMed ID: 27132161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlates of plasma concentrations of per- and poly-fluoroalkyl substances among reproductive-aged Black women.
    Wise LA; Wesselink AK; Schildroth S; Calafat AM; Bethea TN; Geller RJ; Coleman CM; Fruh V; Claus Henn B; Botelho JC; Harmon QE; Thirkill M; Wegienka GR; Baird DD
    Environ Res; 2022 Jan; 203():111860. PubMed ID: 34403666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prenatal exposure to perfluoroalkyl substances and associations with symptoms of attention-deficit/hyperactivity disorder and cognitive functions in preschool children.
    Skogheim TS; Villanger GD; Weyde KVF; Engel SM; Surén P; Øie MG; Skogan AH; Biele G; Zeiner P; Øvergaard KR; Haug LS; Sabaredzovic A; Aase H
    Int J Hyg Environ Health; 2020 Jan; 223(1):80-92. PubMed ID: 31653559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exposure to Perfluoroalkyl Substances and Metabolic Outcomes in Pregnant Women: Evidence from the Spanish INMA Birth Cohorts.
    Matilla-Santander N; Valvi D; Lopez-Espinosa MJ; Manzano-Salgado CB; Ballester F; Ibarluzea J; Santa-Marina L; Schettgen T; Guxens M; Sunyer J; Vrijheid M
    Environ Health Perspect; 2017 Nov; 125(11):117004. PubMed ID: 29135438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prenatal exposure to perfluoroalkyl substances and birth outcomes in a Spanish birth cohort.
    Manzano-Salgado CB; Casas M; Lopez-Espinosa MJ; Ballester F; Iñiguez C; Martinez D; Costa O; Santa-Marina L; Pereda-Pereda E; Schettgen T; Sunyer J; Vrijheid M
    Environ Int; 2017 Nov; 108():278-284. PubMed ID: 28917208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants and Temporal Trends of Perfluoroalkyl Substances in Pregnant Women: The Hokkaido Study on Environment and Children's Health.
    Tsai MS; Miyashita C; Araki A; Itoh S; Bamai YA; Goudarzi H; Okada E; Kashino I; Matsuura H; Kishi R
    Int J Environ Res Public Health; 2018 May; 15(5):. PubMed ID: 29758015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maternal serum concentrations of per- and polyfluoroalkyl substances and their predictors in years with reduced production and use.
    Berg V; Nøst TH; Huber S; Rylander C; Hansen S; Veyhe AS; Fuskevåg OM; Odland JØ; Sandanger TM
    Environ Int; 2014 Aug; 69():58-66. PubMed ID: 24815340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exposure of Norwegian toddlers to perfluoroalkyl substances (PFAS): The association with breastfeeding and maternal PFAS concentrations.
    Papadopoulou E; Sabaredzovic A; Namork E; Nygaard UC; Granum B; Haug LS
    Environ Int; 2016 Sep; 94():687-694. PubMed ID: 27453094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations between perfluoroalkyl acids (PFASs) and maternal thyroid hormones in early pregnancy: a population-based cohort study.
    Webster GM; Venners SA; Mattman A; Martin JW
    Environ Res; 2014 Aug; 133():338-47. PubMed ID: 25019470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transfer of perfluoroalkyl substances from mother to fetus in a Spanish birth cohort.
    Manzano-Salgado CB; Casas M; Lopez-Espinosa MJ; Ballester F; Basterrechea M; Grimalt JO; Jiménez AM; Kraus T; Schettgen T; Sunyer J; Vrijheid M
    Environ Res; 2015 Oct; 142():471-8. PubMed ID: 26257032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association between perfluoroalkyl substances and lipid profile in exposed pregnant women in the Veneto region, Italy.
    Dalla Zuanna T; Savitz DA; Barbieri G; Pitter G; Zare Jeddi M; Daprà F; Fabricio ASC; Russo F; Fletcher T; Canova C
    Ecotoxicol Environ Saf; 2021 Feb; 209():111805. PubMed ID: 33360787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determinants of prenatal exposure to perfluoroalkyl substances in the Slovak birth cohort.
    Richterová D; Fábelová L; Patayová H; Pulkrabová J; Lanková D; Rausová K; Šovčíková E; Štencl J; Hajšlová J; Trnovec T; Palkovičová Murínová Ľ
    Environ Int; 2018 Dec; 121(Pt 2):1304-1310. PubMed ID: 30420127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral contraceptive use as a determinant of plasma concentrations of perfluoroalkyl substances among women in the Norwegian Mother and Child Cohort (MoBa) study.
    Rush EL; Singer AB; Longnecker MP; Haug LS; Sabaredzovic A; Symanski E; Whitworth KW
    Environ Int; 2018 Mar; 112():156-164. PubMed ID: 29274593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prenatal exposure to perfluoroalkyl substances, immune-related outcomes, and lung function in children from a Spanish birth cohort study.
    Manzano-Salgado CB; Granum B; Lopez-Espinosa MJ; Ballester F; Iñiguez C; Gascón M; Martínez D; Guxens M; Basterretxea M; Zabaleta C; Schettgen T; Sunyer J; Vrijheid M; Casas M
    Int J Hyg Environ Health; 2019 Jul; 222(6):945-954. PubMed ID: 31262703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.